𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Naamidine A Is an Antagonist of the Epidermal Growth Factor Receptor and an in Vivo Active Antitumor Agent

✍ Scribed by Copp, Brent R.; Fairchild, Craig R.; Cornell, Laurie; Casazza, Ana Maria; Robinson, Simon; Ireland, Chris M.


Book ID
120170752
Publisher
American Chemical Society
Year
1998
Tongue
English
Weight
68 KB
Volume
41
Category
Article
ISSN
0022-2623

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Antitumor activity of the selective epid
✍ Ichiro Naruse; Tohru Ohmori; Yoko Ao; Hisao Fukumoto; Toshio Kuroki; Masatomo Mo 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 216 KB 👁 1 views

## Abstract Selective tyrosine kinase inhibitors are regarded as promising antitumor agents for cancer treatment. Iressa® (ZD1839) is an orally active, selective EGFR‐TKI (epidermal growth factor receptor‐tyrosine kinase inhibitor) that blocks signal transduction pathways implicated in cancer cell

Analysis of the epidermal growth factor
✍ Mikkel W. Pedersen; Nina Pedersen; Lars Damstrup; Mette Villingshøj; Søren U. Sø 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 799 KB

## Abstract Overexpression or expression of activating mutations of the epidermal growth factor receptor (EGFR) is common in cancer and correlates with neoplastic progression. The present study employed Affymetrix® oligonucleotide arrays to profile genes induced by ligand‐activated EGFR with the re

Differential activation of ErbB receptor
✍ Ezeh, Patrick I. ;Farbman, Albert I. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 300 KB 👁 2 views

Transforming growth factor-␣ (TGF-␣) and epidermal growth factor (EGF) are members of the EGF family of growth factors. They have a common receptor, the EGF receptor. This belongs to the tyrosine kinase group of receptors called the ErbB receptor family. Other members are ErbB-2, ErbB-3, and ErbB-4.